Evidence map›Paper›PMID 36174913›Full record

ReviewThe Canadian journal of cardiology2023

Fetal Brain Development in Congenital Heart Disease.

Shabnam Peyvandi, Caitlin Rollins

Open access · hybridAbstract readReview
In one paragraph

Review in The Canadian journal of cardiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed, 1 pooled it
9.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 1 synthesis or guideline pooled it, 60 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Characterizing fetoplacental response to acute maternal hyperoxygenation in suspected coarctation of aorta using fetal cardiac MRI.Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology · 2025
    Article
  20. Cord blood levels of insulin-like growth factor-1 and insulin-like growth factor binding protein-3 correlate with perinatal brain development in fetal congenital heart disease.Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology · 2025
    Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Shabnam PeyvandiUniversity of California San Francisco Benioff Children's Hospital, San Francisco, California, USA. Electronic address: shabnam.peyvandi@ucsf.edu.
Caitlin RollinsBoston Children's Hospital and Harvard University Departments of Neurology, Boston, Massachusetts, USA.
Boston Children's Hospital · USUniversity of California, San Francisco · US

Funding

The Risk of Acquired Neonatal Significant brain Injury during perinatal Transition in Congenital Heart Disease: TRANSIT CHD studyR01NS125404 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Shabnam Peyvandi · 2022 to 2026
$2.8M
Fetal Brain MRI as a Predictor of Late Neurodevelopmental Outcome in Congenital Heart DiseaseR01NS121334 · NINDS · BOSTON CHILDREN'S HOSPITAL · PI Caitlin Rollins · 2022 to 2026
$2.2M
Fetal Brain Development in Congenital Heart DiseaseK23NS101120 · NINDS · BOSTON CHILDREN'S HOSPITAL · PI ROLLINS, CAITLIN · 2017 to 2022
$1.1M
Fetal markers of neurodevelopmental outcomes in congenital heart diseaseK23NS099422 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI PEYVANDI, SHABNAM · 2017 to 2021
$961k
NINDS NIH HHS K23 NS099422NINDS NIH HHS K23 NS101120NINDS NIH HHS R01 NS121334NINDS NIH HHS R01 NS125404
6 · The paper itself

Abstract

Neurodevelopmental impairments are the most common extracardiac morbidities among patients with complex congenital heart disease (CHD) across the lifespan. Robust clinical research in this area has revealed several cardiac, medical, and social factors that can contribute to neurodevelopmental outcome in the context of CHD. Studies using brain magnetic resonance imaging (MRI) have been instrumental in identifying quantitative and qualitative difference in brain structure and maturation in this patient population. Full-term newborns with complex CHD are known to have abnormal microstructural and metabolic brain development with patterns similar to those seen in premature infants at approximately 34 to 36 weeks' gestation. With the advent of fetal brain MRI, these brain abnormalities are now documented as they begin in utero, as early as the third trimester. Importantly, disturbed brain development in utero is now known to be independently associated with neurodevelopmental outcome in early childhood, making the prenatal period an important timeframe for potential interventions. Advances in fetal brain MRI provide a robust imaging tool to use in future neuroprotective clinical trials. The causes of abnormal fetal brain development are multifactorial and include cardiovascular physiology, genetic abnormalities, placental impairment, and other environmental and social factors. This review provides an overview of current knowledge of brain development in the context of CHD, common prenatal imaging tools to evaluate the developing fetal brain in CHD, and known risk factors contributing to brain immaturity.

Indexed as

Heart Defects, CongenitalPlacentaBrainChild, PreschoolFemaleFetusHumansInfantInfant, NewbornMagnetic Resonance ImagingPregnancy

Identifiers

PMID36174913
PMCPMC9905309
OpenAlexW4297106203

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.